FCM
ABBV icon

Fortis Capital Management’s AbbVie ABBV Stock Holding History

Fortis Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.02M Buy
8,042
+862
+12% +$185K 0.23% 73
2026
Q1 		$1.56M Buy
7,180
+380
+6% +$84.3K 0.16% 74
2025
Q4 		$1.55M Buy
6,800
+1,669
+33% +$380K 0.21% 68
2025
Q3 		$1.19M Buy
5,131
+116
+2% +$23.6K 0.17% 70
2025
Q2 		$931K Buy
5,015
+619
+14% +$115K 0.14% 78
2025
Q1 		$921K Sell
4,396
-813
-16% -$158K 0.18% 70
2024
Q4 		$926K Sell
5,209
-697
-12% -$128K 0.17% 76
2024
Q3 		$1.17M Buy
5,906
+26
+0.4% +$4.85K 0.23% 68
2024
Q2 		$1.01M Sell
5,880
-4,358
-43% -$722K 0.22% 71
2024
Q1 		$1.86M Buy
10,238
+237
+2% +$40.8K 0.49% 44
2023
Q4 		$1.55M Buy
10,001
+1,688
+20% +$246K 0.4% 61
2023
Q3 		$1.24M Buy
8,313
+803
+11% +$118K 0.39% 58
2023
Q2 		$1.01M Sell
7,510
-122
-2% -$17.9K 0.36% 51
2023
Q1 		$1.22M Buy
7,632
+453
+6% +$69.3K 0.49% 33
2022
Q4 		$1.16M Sell
7,179
-102
-1% -$15.6K 0.86% 24
2022
Q3 		$977K Buy
7,281
+45
+0.6% +$6.46K 0.83% 32
2022
Q2 		$1.11M Sell
7,236
-514
-7% -$78.5K 1.09% 23
2022
Q1 		$1.26M Buy
7,750
+408
+6% +$59.3K 0.64% 39
2021
Q4 		$994K Sell
7,342
-18,015
-71% -$2.13M 0.52% 45
2021
Q3 		$2.73M Buy
25,357
+19,846
+360% +$2.27M 1.46% 12
2021
Q2 		$621K Buy
5,511
+1,948
+55% +$219K 0.32% 87
2021
Q1 		$386K Buy
3,563
+1,157
+48% +$124K 0.22% 95
2020
Q4 		$258K Buy
+2,406
New +$231K 0.2% 73

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fortis Capital Management's ABBV Position: Q2 2026 in Review

Fortis Capital Management increased its AbbVie (ABBV) stake by 12% in Q2 2026, buying an estimated $185K and bringing the position to 8,042 shares worth $2.02M. The position accounts for 0.23% of the portfolio, ranked #73.

Fortis Capital Management first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. The position peaked at $2.73M in Q3 2021. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Fortis Capital Management held 8,042 shares of AbbVie worth $2.02M as of Q2 2026.
  • Fortis Capital Management bought 862 AbbVie shares in Q2 2026, an estimated $185K.
  • AbbVie made up 0.23% of Fortis Capital Management's portfolio in Q2 2026, its #73 holding.
  • Fortis Capital Management first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
  • Fortis Capital Management's AbbVie position peaked at $2.73M in Q3 2021.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Fortis Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.